2005
DOI: 10.1007/s11274-004-2609-2
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of the active site of the extracellular β-D-glucosidase from Aspergillus carbonarius

Abstract: The catalytic amino acid residues of the extracellular b-D-glucosidase (b-D-glucoside glucohydrolase, EC 3.2.1.21) from Aspergillus carbonarius were investigated. The pH dependence curves gave apparent pK values of 2.8 and 5.93 for the free enzyme, and 2.24 and 6.14 for the enzyme-substrate complex using p-nitrophenyl-b-D-glucoside as substrate. Carbodiimide-and Woodward reagent K-mediated chemical modifications suggested that a carboxylate residue, located in the active centre, was fundamental in the catalysi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 35 publications
1
7
0
Order By: Relevance
“…The activity of the Asp2863Ala mutation was too low for the K m to be accurately determined; thus, the apparent k cat was estimated. The decrease in the catalytic activity of this mutant of approximately 4 to 5 orders of magnitude (Table 3) coupled with the observation that this residue aligns with previously identified catalytic nucleophilic residues in GH3 enzymes (2,9,11,31,34,35,40) provides support for the assignment of Asp286 as the catalytic nucleophile for Xyl3B.…”
Section: Discussionsupporting
confidence: 80%
“…The activity of the Asp2863Ala mutation was too low for the K m to be accurately determined; thus, the apparent k cat was estimated. The decrease in the catalytic activity of this mutant of approximately 4 to 5 orders of magnitude (Table 3) coupled with the observation that this residue aligns with previously identified catalytic nucleophilic residues in GH3 enzymes (2,9,11,31,34,35,40) provides support for the assignment of Asp286 as the catalytic nucleophile for Xyl3B.…”
Section: Discussionsupporting
confidence: 80%
“…Owing to these drawbacks, no active site residue could be identified using this inactivator. Finally, the N-bromoacetyl glycosylamines and bromoketone C-glycosides (represented by the general structures 3f-h) have been used to label and inactivate several glycosidases (Naider et al 1972;Black et al 1993;Keresztessy et al 1994;Tull et al 1996;Howard and Withers 1998a,b;Chir et al 2002;Kiss et al 2002;Vocadlo et al 2002;Jager and Kiss 2005). Unlike the classes of compounds 3a-e discussed above, the N-bromoacetyl glycosylamines and bromoketone C-glycosides have typically proven to be sufficiently stable toward spontaneous decomposition to be useful as labeling agents when care is taken to select the proper inactivator, as described below.…”
Section: Other Affinity Labelsmentioning
confidence: 99%
“…Interestingly, this is the same methionine as that which was labeled by the galactosylmethyl triazene described above (Sinnott andSmith 1976, 1978;Fowler et al 1978). In a second case in which this reagent was employed, the authors propose that the catalytic nucleophile is the site of labeling on the basis of the pH dependence on the rate of inactivation and the pH/rate profile of enzymatic substrate hydrolysis (Jager and Kiss 2005). However pH/rate profiles can be notoriously difficult to interpret (Knowles 1976), so in the absence of a structural study and a detailed kinetic analysis of both wild-type and site-directed mu-tants (see Vocadlo et al 2002 for a good example of this type of analysis), caution should be exercised.…”
Section: Other Affinity Labelsmentioning
confidence: 99%
“…13,44,77−79,81,83−85 However, the inactivation constants, k i , for other N-bromoacetylglycosylamine inhibitors are 2−3 orders of magnitude lower. 13,44,[77][78][79]81,83,85 The large error on the apparent K i value, in this case, reflects an apparently poor ability to saturate the enzyme and a correspondingly flat k app vs [I] curve (see Figure S2). Similarly, saturation inhibition kinetics were not achieved with the tetrasaccharide inhibitor GGG3G-β-NHCOCH 2 Br (compound 5; see Figure S3 in the Supporting Information).…”
Section: ■ Results and Discussionmentioning
confidence: 91%